Insmed Incorporated (INSM) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Insmed (INSM) Q1 2026: Brinsupri Delivers 44% Sequential Growth, Underpinning Long-Term Expansion
May 08, 2026
-
INSM Q4 2025: Brensupri Launch Drives $1B+ 2026 Guide, Unlocking Bronchiectasis Market Expansion
February 24, 2026
-
Insmed (INSM) Q3 2025: Brinsupri Launch Drives $28M in Six Weeks, Setting Up Multi-Asset Growth Cycle
October 30, 2025
-
Insmed (INSM) Q2 2025: $823M Capital Raise Powers Brenzocatib Launch and Pipeline Acceleration
August 07, 2025
-
Insmed (INSM) Q1 2025: 50% International Growth Sets Stage for Brenzocatib Launch
July 06, 2025